Respiratory Syncytial Virus Market: Comprehensive Study by Key Players - AbbVie, Inc., AstraZeneca PLC, Bausch Health Companies Inc., Atea Pharmaceuticals
The global respiratory syncytial virus (RSV) market held a market size of USD 1,669.5 Million in 2020 and is anticipated to grow at a CAGR of 14.9% from 2017 to 2027.
View full press release